Visiopharm · Pathology image analysis software
A design based stereology solution
About Visiopharm
Careers
Leadership
APP Center
Book a demo
Book Academy Course
Challenges in IHC staining consistency
Contact us
Cookie policy
Customer stories
Customer survey terms and conditions
Diagnostic tissue analysis
Discovery
ESG policy
Free digital pathology resources
Grundium scanner for Qualitopix
haf block backup
Home
Legal Notice
Mindkey Application Page
Mindkey Details Page
Mindkey Thank you page
Newsletter sign-up
Newsroom
PACS-IMS Integrations
Pharma Services
Privacy policy
Publications
Qualitopix
Qualitopix – Register – Form
Request demo for Subscriptions
Request training
Research Solutions
Phenoplex – Multiplex software for multiplex users in spatial biology
Scanners for digital image analysis
Support
Testpage haf
Thank you – academy
Tissue Micro Arrays with Tissuearray™
Tissuealign
Training
Upcoming events
Virtual Double Staining
Work email
HER2 APP, breast cancer based algorithm for precise scoring of HER2-null, ultra-low, and low expression as an alternative to ASCO/CAP visual scoring: an analysis of 422 cases
Written by
in
←
Spatial Immunometabolic Profiling of Non-Small Cell Lung Cancer Reveals Distinct Immune Exclusion Patterns and Functional Niches
Chromogenic Multiplex: The Future of Clinical Biomarkers
→
More posts
Stratipath and Visiopharm partner to advance implementation of AI-Powered Breast Cancer Diagnostics
September 2, 2025
Visiopharm software updates: 2025.08.1
August 19, 2025
Alimentiv’s digital pathology innovation with Visiopharm: an interview with Dr. Pavine Lefevre
April 25, 2025
Improving bladder cancer grading with AI-driven image analysis: A conversation with Prof. David Berman
April 15, 2025